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ABSTRACT: Developmental delays and conditions are common in early childhood, and are 
predictive of later learning and behavioral difficulties. Early treatment improves outcomes. For this 
report, a literature review was conducted to determine the effectiveness of current efforts by 
primary care providers to detect developmental delays in early childhood. Although data are 
limited, there appears to be significant under-detection of developmental delays in early childhood. 
While the prevalence of developmental delays is at least 10 percent, early intervention programs 
aimed at addressing these concerns serve only 2.3 percent of children under age 3. Use of validated 
developmental screening tools is supported by American Academy of Pediatrics guidelines, but 
these instruments are neither widely nor systematically used in pediatric practice. The report makes 
several recommendations to strengthen developmental surveillance and screening, and thereby 
improve outcomes for young children and families. 
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 EXECUTIVE SUMMARY 
 
 
Developmental delays and conditions are common in early childhood, affecting at 
least 10 percent of children. Early developmental delays are markers for later 
developmental conditions such as autism, intellectual disability, hearing or vision 
impairment, cerebral palsy, speech and language disorders, and learning disabilities. Risk 
factors such as family poverty, parents’ mental illness, and child neglect and abuse increase 
the likelihood of developmental delays. 
 
Recent studies emphasize the importance of the interaction of brain development 
and environment on children’s developmental and behavioral outcomes. The tremendous 
adaptability of the brain in the first three years of life means that early treatment of delays 
leads to improved outcomes, whereas later intervention is less effective. In order to 
provide treatment to improve children’s outcomes, early identification of delays and 
sensory impairments (i.e., vision and hearing problems) is critical. 
 
Pediatricians and other primary care medical providers who see children for 
regularly scheduled preventive care visits during their first three years of life, and who are 
trained in child development, could play a key role in the early identification of 
developmental delays. For this report, a literature review was conducted to determine the 
effectiveness of current efforts by primary care providers to detect developmental delays in 
early childhood and to consider ways to improve. 
 
Key Findings 
According to the literature review, early developmental delays are often not identified in a 
timely way. Many children are not identified until kindergarten entry or later—well beyond 
the period in which early intervention is most effective. Therefore, in many cases, 
opportunities to intervene early to improve children’s developmental outcomes are missed. 
 
To monitor children’s development, pediatricians and other primary care medical 
providers rely mainly on informal developmental milestones and their clinical impressions. 
Validated developmental screening tools that could increase identification of 
developmental delays exist, but most physicians do not use them systematically to screen 
all patients. Recently revised guidelines from the American Academy of Pediatrics 
recommend routine screening at three specific ages in early childhood, and may lead to 
the increased use of screening tools. 
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 Given the prevalence and impact of developmental conditions in childhood, the 
number of scientific studies in this area is surprisingly limited. 
 
Recommendations 
The following steps could promote early identification of developmental delays in 
young children: 
 
• Research is needed to: 1) elucidate the reasons for the gap between the prevalence of 
developmental conditions and their identification in early childhood; 2) document 
the effectiveness of physicians’ developmental monitoring and screening efforts 
over time, as policies to encourage developmental screening are implemented; and 
3) understand and address any negative consequences of developmental screening, 
such as increasing parental anxiety. 
• Financial, educational, and other barriers to the use of developmental screening 
tools need to be addressed to increase physicians’ use of these tools. 
• Residents in pediatrics and family medicine need to be trained to use developmental 
screening tools as part of the routine care of pediatric patients, to ensure that the 
next generation of providers is ready to use developmental screening tools. 
• Resources are needed to develop high-quality screening tools that are available in 
the public domain and are compatible with electronic medical records. 
• Communication models need to be developed to assist physicians in discussing 
with families the implications of developmental screening test results. 
• Adding a 30-month preventive care visit to the well-child visit schedule, as 
recommended by organizations such as Bright Futures, would increase the number 
of opportunities to provide developmental screening and identify developmental 
delays at a critical time in young children’s development. 
• Successful models to promote developmental screening, such as the Assuring Better 
Child Health and Development (ABCD) program in North Carolina, need to be 
spread to other states. This is already occurring through the ABCD Screening 
Academy, jointly sponsored by National Academy for State Health Policy and 
The Commonwealth Fund. 
 
Systematic developmental screening will mean that greater numbers of children 
with developmental delays are identified. Planning and resource allocation at the state and 
federal levels are needed to ensure sufficient resources for their evaluation and treatment. 
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 DEVELOPMENTAL SCREENING IN PRIMARY CARE: 
THE EFFECTIVENESS OF CURRENT PRACTICE 
AND RECOMMENDATIONS FOR IMPROVEMENT 
 
 
INTRODUCTION 
Developmental delays and conditions affect at least 10 percent of children in the United 
States.1 Delays in the development of speech and language as well as fine motor, gross 
motor, social, and problem-solving skills in early childhood are markers for specific 
developmental conditions, including speech and language disorders, learning disabilities, 
cognitive disability (mental retardation), autism spectrum disorders, cerebral palsy, and 
vision or hearing impairment. Language delays affect at least 5 percent to 10 percent of 
young children.2–4 An estimated 8 percent of children have a learning disability5 and 1 
percent to 1.5 percent of children have a cognitive disability (Table 1).6,7 Many children 
have delays in more than one developmental domain.8 Factors that place young children at 
increased risk for developmental delays include low maternal educational attainment,9 
poverty,10 maternal depression or mental health issues,11,12 lead poisoning,13,14 premature 
birth,15 suboptimal nutrition (including failure to thrive16 and anemia17), and male gender.1
 
Developmental delays and disabilities have important impacts on society in terms 
of the costs of providing health care, educational support, and ongoing services. In 
addition, they have indirect costs, such as lost income potential for affected individuals 
over their lifespan. Substantial resources are expended for the educational, medical, and 
community support of individuals with developmental delays and conditions.18,19 Affected 
children have significantly increased rates of health care use compared with children 
without such conditions.1,20 The economic costs to society associated with developmental 
conditions, including expenditures for additional medical care and indirect costs related to 
lost productivity, were estimated to be an average of $1,014,000 over the lifetime for an 
individual with mental retardation, $921,000 for an individual with cerebral palsy, and 
$417,000 for an individual with hearing impairment in 2003 dollars.21
 
Early treatment of developmental delays leads to improved outcomes for children, 
and therefore reduced costs to society. Early intervention has been shown to be 
particularly effective at improving outcomes for children who are at increased risk for 
developmental delays, or later academic underachievement, based on socioeconomic, 
medical, or other risk factors.22–25 A systematic review of early childhood development 
programs aimed at narrowing the achievement gap for children at risk because of poverty 
found that participation in such programs resulted in a mean 14 percent reduction in 
 1
 special education placement later in childhood, 13 percent reduction in not passing a grade 
in school, and an increase in IQ test scores of about 6.5 points.26 In addition, participation 
had significant long-terms benefits in terms of reducing rates of teen pregnancy, increasing 
rates of high school graduation, and increasing rates of employment in early adulthood.26 
The Infant Health and Development Program, a randomized, multi-site trial of a 
comprehensive early intervention effort aimed at premature children, from birth to 36 
months, demonstrated sustained benefits, particularly for heavier infants in the cohort.23,27
 
Early identification is supported by federal legislation under Part C of the 
Individuals with Disabilities Act (IDEA), which provides program support to promote 
community-based efforts to identify young children with or at risk for developmental 
conditions, as well as treatment for affected children under age 3.28 In 2005, federal funds 
allocated under IDEA Part C totaled $440.8 million. Federal appropriations of $11.6 
billion—26 times what is spent on early intervention—were made under IDEA Part B, 
which supports special education for children and youth ages 3 to 21. Head Start programs 
received $6.84 billion in federal funding in 2005 to serve children 3 to 6 years of age at 
increased risk of poor educational outcomes due to poverty.29
 
In order to benefit from early intervention, children with developmental delays 
and conditions must be identified and referred at a young age.24,30 Primary care physicians 
have the opportunity to monitor young children’s development during 14 recommended 
health supervision visits between birth and age 5,31,32 are trained in child development and 
behavior,33 and are therefore ideally suited to identify developmental delays. 
 
The findings in this report are based on a review of the literature. The objectives 
of the review were to: 
 
• assess the effectiveness of current primary care practices in the identification of 
developmental delays in young children; 
• describe current practices related to the identification of developmental delays; and 
• identify factors that affect current practice. 
 
This report summarizes the existing research on the content and effectiveness of 
current practice and provides recommendations for future research and policy 
development. Such a review is timely, given that the American Academy of Pediatrics 
(AAP) published in 2006 revised practice guidelines on developmental surveillance and 
screening in the primary care setting.34
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 METHODS 
This review builds on prior reviews on the topic of developmental screening and the 
identification of developmental delays. These include: clinically oriented studies that 
provide an overview of the approach to identifying developmental delays35,36 or criteria 
for selecting a developmental screening test from among available tools;37–39 reviews that 
focus on the role of parents in identifying developmental delays;40 reviews of general 
research findings41 (which occurred prior to the most recent two revisions of AAP practice 
parameters on developmental surveillance and screening);34,42 and a review of primary care 
services that promote healthy development for children under age 3.43
 
For this report, a literature search was conducted using the PubMed and PsychInfo 
databases to identify peer-reviewed studies related to the identification of children with 
developmental delays in the primary care setting. Studies included in the review were 
published between 1986 and 2006, with a focus on U.S. and Canadian studies. Search terms 
included developmental delay, developmental screening, developmental surveillance, and 
primary care. The definitions of developmental surveillance, screening, and assessment 
used are summarized in Table 2. Validation studies of developmental screening measures 
were not included, nor were studies of screening in settings other than primary care 
(e.g., high-risk follow-up clinics or community-based screening programs). 
 
The review identified several types of studies: 1) practice guidelines on developmental 
surveillance and screening from professional organizations;34,42,44–48 2) studies of the use of 
developmental screening tools in primary care settings;49–52 3) surveys of physicians on 
their developmental surveillance and screening practices;53–57 4) surveys of parents that 
included information about experiences related to screening or identification in primary 
care;58–63 5) retrospective chart reviews or other studies of identification patterns from 
referral clinics;64–66 and 6) economic analyses of developmental screening.67,68 No 
randomized controlled trials or case control studies of developmental screening in the 
primary care setting were identified. A single prospective cohort study in the primary care 
setting was identified.52
 
RESULTS 
Evidence for the Effectiveness of Current Practices 
Prevalence of Delays Versus Rates of Participation in Treatment Services 
One way to determine the effectiveness of current efforts in primary care to identify 
developmental delays is to compare rates of identification, as measured by participation in 
early intervention services, to the known prevalence of these conditions. While the 
prevalence of delays in young children is at least 10 percent, only 2.3 percent of children 
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 between birth and age 3 participated in IDEA Part C Early Intervention (EI) programs in 
2005.69 This means that nearly four of five potentially eligible children did not participate. 
 
Participation rates in EI programs vary widely by state: from 1.28 percent of all 
children under age 3 in Alabama to 7.09 percent in Hawaii in 2004.69 The variation is 
due, in part, to differences among the states in terms of whether children deemed to be at 
risk for delays are eligible for the programs. Across all U.S. states, preschool special 
education programs under IDEA Part B for children ages 3 to 5 served 5.87 percent of 
children on average in 2004,70 or 2 1/2 times as many children as are served by Part C. 
The differences in rates of participation between states mean that a child’s developmental 
outcome may be determined in part by his or her state of residence. 
 
Age of Child at Initial Parental Concern Versus Age at Diagnosis 
Another way to determine the effectiveness of current detection efforts is to examine the 
experiences of children diagnosed with developmental conditions. Two studies reported 
on age at presentation for developmental concerns to specialty diagnostic clinics.64,65 The 
first reported on age at referral compared with the type of developmental diagnosis among 
a group of patients evaluated in the early 1980s.64 Whereas the median age of presentation 
for a child diagnosed with cerebral palsy was 11 months, children were referred for 
evaluation of mental retardation/global developmental delays at a median age of 27 
months and for communication disorders at 32 months.64 The severity of the condition 
did not affect the age at referral. Yet, it is likely that children referred for such evaluations 
represented the most severe cases, and that milder cases, which are the most amenable to 
treatment, were not seen for referral. 
 
The second study evaluated referral patterns in Canada in the late 1990s.65 On 
average, parents reported that they had concerns when their child was 23 months and had 
an assessment 15 months later, at 38 months.65 For children diagnosed with global 
developmental delays, mean age at initial parental concern was 19 months, with assessment 
on average 16 months later, at 35 months. For children with speech and language delays, 
parents had concerns at a mean age of 27 months, with assessment on average 16 months 
later, at 43 months. Overall, most parents had concerns about their child’s development 
during the second year of life, but diagnostic assessments by specialists were often not 
conducted until age 3 1/2 or 4. The authors noted that the wait to be seen in the specialty 
clinic for assessment accounted for only a small part of the lag, and speculated that a large 
part was related to a “watch and wait” approach taken by referring physicians. 
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 A study that interviewed mothers of boys with Fragile X syndrome, a genetic 
condition associated with developmental delays, reported that, on average, parents had 
concerns at nine months, with recognition by the primary care medical provider of the 
child’s developmental delay at 24 months and diagnosis of Fragile X at 35 months. Many 
families reported that physicians discounted their concerns at first, or were told that it was 
too early to tell if there was a problem.66
 
A population-based study of the prevalence of speech and language impairment 
among a large group of children tested in kindergarten in the 1990s found that, among 
those with speech and language impairment, 71 percent had not been diagnosed before 
the study.2 There was no difference in severity between children identified before school 
entry or during kindergarten. According to this study, the majority of children with 
significant speech and language problems are not receiving the benefit of early 
identification and treatment. 
 
Referral Patterns for Children Receiving Treatment Services 
A third way to examine the effectiveness of current detection practices is by studying 
referral patterns for children enrolled in treatment services. A recent national study 
reported on the experiences of families of children participating in IDEA Part C Early 
Intervention services who had a signed service plan before their children were 31 months 
old.61,62 On average, families reported a concern about their child at 7.4 months, received 
a diagnosis 1.4 months later, were referred to Early Intervention programs 5.2 months 
after the diagnosis, and had a service plan developed 1.7 months later, at 15.7 months of 
age.61 About one-quarter of children entered the program early, by seven months old, and 
about one-quarter started the program later, between 23 and 30 months. Children starting 
EI programs sooner tended to have a diagnosed condition or risk factor (e.g., prematurity), 
whereas those with later entry tended to have developmental delays. Families with 
children entering EI programs later were less likely to have discussed their concerns with a 
medical professional, and less likely to report that the professional had been helpful. The 
waiting times to diagnosis for children actually receiving EI services therefore appears to 
be significantly shorter than the waiting time for diagnosis among all children with 
developmental conditions. Unfortunately, as discussed above, children participating in EI 
services represent only a small proportion of children with developmental conditions. 
 
A multi-site, community-based study conducted in the 1980s of children in 
kindergarten through sixth grade who were receiving special education services provides 
the most comprehensive information available on the timing of identification for children 
with developmental delays.60 Rare but severe conditions such as Down syndrome and 
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 cerebral palsy were likely to be identified early, often by physicians. In contrast, milder, 
more common conditions such as speech and language disorders were unlikely to be 
identified by physicians (only 19%; most were identified by other professionals, such as 
educators) and were identified later, usually at school entry. 
 
Children who are not served through EI or special education programs may 
participate in other therapy services, such as those available through their family’s health 
insurance. Still, these findings imply that the majority of children with developmental 
delays may not be identified until school entry, at kindergarten or later. In general, 
children with milder conditions—those most likely to have a significant response to 
treatment—are less likely than those with more serious conditions to be identified early. 
 
Current Primary Care Practices to Identify Children with Developmental Delays 
Given the evidence of under-detection of developmental delays and conditions in early 
childhood, what do the practice guidelines recommend and how do primary care 
physicians’ actual practices compare with these guidelines? 
 
Practice Guidelines 
The American Academy of Pediatrics (AAP) has issued a number of policy statements 
related to the identification of developmental delays from primary care. A 2001 statement, 
“Developmental Surveillance and Screening of Infants and Young Children,”42 a revision of 
an earlier version,44 emphasized the important role of pediatricians in early identification. 
The committee recommended that “all infants and young children should be screened for 
developmental delays.”42 Pediatricians were encouraged to incorporate use of a 
developmental screening tool appropriate for their population, with the recommendation 
to “perform periodic screenings of all infants and young children during preventive care 
visits.” Guidelines on the frequency or timing of screening were not provided. 
 
The AAP statement was revised recently, incorporating more specific 
recommendations for the timing of formal screening (Table 3).34 The AAP now recommends 
that all health supervision visits before age 5 include developmental surveillance, with use 
of a standardized screening tool whenever a concern is raised by a parent or identified by a 
physician. General developmental screening of all children using a standardized tool is 
recommended at three specific ages (9, 18, and 30 or 24 months), with additional 
screening for autism at 18 months. There has been some difference of opinion in the field 
between the need for developmental surveillance or ongoing monitoring35,71 versus 
systematic screening of all children using a validated tool.42 The current practice guidelines 
address this issue by recommending screening of all children at specific ages, and 
monitoring of development at all other visits during the first 5 years of life. 
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 Use of General Versus Condition- or Domain-Specific Screening Tools 
Two types of developmental screening tools exist: general tools that address multiple 
developmental domains and tools that are either condition-specific, aimed at identifying a 
specific developmental condition (e.g., autism), or domain-specific, aimed at screening a 
particular area (e.g., speech and language). Recommendations have focused on general 
tools, although the most recent AAP statement endorses the use of an autism-specific 
screen at the 18-month visit, even in the absence of a suspicion of autism.34 This 
recommendation differs from practice guidelines from the American Academy of 
Neurology and the Child Neurology Society on the screening and diagnosis of autism, 
which recommend routine use of a general developmental screening tool, with secondary 
screening with an autism-specific tool if a child fails the general screen or if specific delays 
or deficits are noted.45,47
 
Condition- or domain-specific tools are not typically recommended for general 
screening in primary care. In the area of speech and language development, the U.S. 
Preventive Services Task Force recently concluded that there is insufficient evidence to 
recommend the use of specific screening to detect speech and language delays in young 
children at the current time.46,48
 
Physician Practice 
Although practice guidelines from the American Academy of Pediatrics recommend the 
use of developmental screening tools in primary care, most physicians do not appear to use 
these tools systematically, if at all. In surveys, most physicians report using developmental 
milestone lists or informal checklists as part of an overall strategy of developmental 
surveillance.54,56,57 About half of physicians report using a validated developmental 
screening instrument,54 though most use the tools selectively, rather than systematically 
with all patients.57 Among physicians who use a screening tool, the Denver-II instrument 
is most commonly used,54 despite concerns that this tool lacks the sensitivity needed to 
effectively identify children with delays.72
 
In a national survey, parents of children between the ages of 10 to 35 months were 
asked whether their child had ever received a “developmental assessment,” defined as a 
formal or informal assessment or screening done by a health care provider, with or 
without the use of a validated screening tool.58 More than 40 percent of parents reported 
that their child had never received such an assessment. Parents who reported that their 
children had received a developmental assessment were more likely to be satisfied with 
their child’s medical care; these visits were also associated with higher quality ratings. 
These results suggest that providers and practices who take a structured approach to 
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 developmental assessment are providing a higher level of care overall, thereby potentially 
contributing to improved child health outcomes. 
 
The Role of Structured Developmental Screening in Primary Care 
Review of the literature identified few studies of developmental screening delivered by 
pediatricians as part of preventive care in actual primary care settings. As part of the North 
Carolina Assuring Better Child Health and Development (ABCD) program, use of a 
parent-completed developmental screening tool, the Ages & Stages Questionnaire 
(ASQ),73 was implemented among a network of primary care practices.50,51 Screening rates 
increased from 15 percent of visits at baseline to more than 70 percent of designated health 
supervision visits after implementation.51 Increased rates of screening translated into 
increases in referral to EI programs, from 2.6 percent of children at baseline to 7 percent 
to 8 percent.50 The study did not report on the accuracy of the screening results or the 
characteristics of the children and providers. 
 
A recent study of developmental screening with the ASQ at the 12- and 24-month 
visits among primary care practices in Oregon found that 54 percent of forms were 
returned by parents. Use of the ASQ led to a 224 percent increase in referral rates for 
developmental concerns, compared with baseline practice.52
 
Most studies of developmental screening in practice have reported positive results 
in terms of increased rates of detection/referral and/or parental satisfaction. Yet, one study 
in a community practice in Canada had mixed results. It examined the accuracy of two 
screening tools, the ASQ73 and the Child Development Inventory (CDI),74 at the 18-
month health supervision visit.49 While the authors concluded that use of these parent-
completed questionnaires was feasible, the sensitivity of both measures in terms of 
correctly identifying those children who have an actual developmental delay, and the 
specificity of the ASQ in terms of avoiding false positive results, were found to be 
significantly lower than expected. Incorporating physicians’ opinion about a child’s 
developmental status did not increase the accuracy of either screening tool. Although the 
study raised concerns about the accuracy of single-point screening at the 18-month visit in 
community practice settings, a number of serious limitations and concerns about the study 
exist and have been commented on in letters to the editor.75,76 In particular, 40 percent of 
children in this sample of middle-class families failed the ASQ screener (i.e., the screening 
result suggested a concern about the child’s development), an unusually high rate. Most 
other studies of the use of this tool among comparable populations have found failure rates 
closer to 10 percent. 
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 In summary, few published studies of the use of developmental screening tools in 
primary care settings exist. Studies examining the effect of standardized screening on rates 
of referral to Early Intervention services have generally demonstrated a significant increase 
in identification of developmental delays and referrals to Early Intervention services. 
 
Factors Influencing Developmental Surveillance and Screening in Primary Care 
Studies have identified a number of factors that affect the delivery of developmental 
surveillance and screening in primary care, and physicians’ ability to identify 
developmental delays in a timely way. First, structural barriers related to the timing of 
health supervision visits and access to care can reduce the likelihood of early detection. 
Between birth and age 2, children are scheduled for 10 health supervision visits. Beginning 
at age 2, the recommended schedule of health supervision visits is only yearly.31,32 
Opportunities to monitor children’s development therefore decrease significantly after age 
2, although increasingly complex language, social interactions, and understanding begin to 
emerge. In addition, although according to AAP recommendations a child should have 14 
health supervision visits before school entry, ideally by a provider who is familiar with the 
child and family, this may not occur in practice.77–79 A study of 81 health plans found that 
only 31 percent of Medicaid enrollees had more than six health supervision visits by age 
15 months, compared with 53 percent of children with private insurance. Fifty percent of 
Medicaid enrollees had yearly check-ups between ages 3 and 6, compared with 55 percent 
of those enrolled in private insurance.77 Even with private health insurance, only slightly 
more than half of children received the recommended number of preventive care visits. 
The rates of adherence were even lower among children covered by Medicaid, who are 
actually at greater risk for developmental problems due to family poverty. 
 
Beyond these systems issues (concerns that the current preventive care visit 
schedule is not optimal for the goal of monitoring children’s health after age 2, and limited 
adherence to the existing schedule of visits by families) which affect the delivery of 
preventive health care services in general, physicians identify a number of barriers to the 
use of developmental screening tools. These include: a lack of time to administer screens 
during health visits; inadequate compensation; lack of training in the use of specific tools; 
and lack of, or perceived lack of, assessment and treatment resources.54,55,57
 
Cost as a Barrier to Developmental Screening 
Cost is one of the most frequently cited barriers to the use of formal screening tools cited 
by physicians. Two studies gauged the costs of different methods of developmental 
screening in primary care. One analysis compared the use of a parent-completed survey 
with two screening tests administered by a professional.67 In terms of short-term costs to 
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 physicians, the study found significant differences, with parent concern questionnaires 
entailing lower costs to the provider to administer and interpret. When long-term costs 
and benefits to society were considered there was no significant difference between the 
two approaches. The authors concluded that much of the cost of the screening was borne 
by clinicians, who were not adequately compensated for their time and efforts. 
 
A second study estimated the cost of developmental and behavioral screening of 
children from birth to age 3 using a variety of approaches, with screening occurring at 
least every six months and as frequently as every health supervision visit.68 From the 
perspective of providers, the primary driver of cost was the time and staffing required to 
administer, score, and interpret the screen. Parent-completed questionnaires entailed the 
lowest costs and physician-administered tools entailed the highest costs. 
 
Based on this evidence, use of parent-completed screening tools seems to be a 
cost-effective alternative to traditional provider-administered tools. 
 
Physician and Child Characteristics 
Both physician and patient characteristics affect physicians’ assessment and management 
decisions. In response to case vignettes describing children with likely developmental 
delays, female physicians were more likely than male physicians to report that they would 
provide a referral. Pediatricians were more likely than family physicians to say they would 
provide referrals.55 In response to a vignette describing an 18-month-old child with 
probable language delay, only 41 percent of physicians said they were likely to refer the 
child to Early Intervention services.55 These findings highlight opportunities to provide 
training to primary care physicians on when referrals for developmental services might be 
appropriate, and to enhance training of family physicians as well as pediatricians. 
 
Limited Sensitivity and Specificity of Available Screening Tools 
There are a number of developmental screening tools that are suitable for use in primary 
care.34 The choice of tool depends on physicians’ preferences and the characteristics of the 
population served. The sensitivity and specificity of these tools are limited, however, with 
general screening tools achieving moderate levels of sensitivity and specificity (mid-80s, 
i.e., the screens accurately identify around 80% of children with an actual developmental 
problem; and correctly classify 80% of children who do not have a developmental delay, as 
not having a problem) at best (Table 4).34 This is because developmental skills are innately 
difficult to measure, characterized by broad normal variation, and are constantly changing. 
Limitations in the screening tools’ sensitivity and specificity can lead to misclassification of 
children’s developmental status (i.e., false positives and false negatives). There is evidence, 
however, that children with a false positive screen (those who fail screening but are not 
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 found to have a clinically significant delay on further assessment) are at greater risk than 
those who pass initial screening for suboptimal scores when their development is formally 
assessed, and may therefore benefit from closer monitoring.80
 
Sharing the Results of Surveillance or Screening with Families 
A recent survey found that 64 percent of physicians believed an established diagnosis (as 
opposed to a less specific concern about a “delay”) is important for referral to EI services, 
and this perception was associated with a decreased likelihood of referral for child with 
speech delay.53 Such beliefs, together with physicians’ discomfort in discussing the 
implication of a positive result on a developmental screening test, mean that even when 
children are identified as being at increased risk, they might not be referred in a timely 
way. The literature on “breaking the news” of a developmental condition to parents for 
diagnoses such as Down syndrome, autism, cognitive disability, cerebral palsy, or 
neurological disability is well developed.81–83 These studies and the resulting recommendations 
focus on care in the inpatient hospital setting. No parallel literature exists to guide 
physicians on effective strategies to discuss the results of developmental screening with 
families in primary care settings, when the ultimate diagnosis may be much less clear. 
 
CONCLUSIONS 
This review found convincing evidence of suboptimal rates of detection of developmental 
delays in early childhood. Although current scientific data are somewhat limited, there is 
evidence of a significant gap between the known prevalence of developmental delays and 
conditions and the much lower rates of participation in educational and therapy programs 
that are the mainstay of treatment. Data suggest a significant delay, often of a year or 
more, between the time at which parents first have a concern about their child’s 
development and the child’s eventual assessment and treatment.61,64–66 The majority of 
children with cognitive disabilities or speech/language disorders not associated with a 
medical risk factor do not appear to be initially identified by physicians.2,60 Many affected 
children may not be identified before school entry. Opportunities to identify problems 
and provide treatments during the early developmental period, when they are most likely 
to lead to improved outcomes, are therefore missed. 
 
Although practice guidelines from professional organizations recommend the use 
of formal developmental screening tools as part of preventive care visits with young 
children, a significant gap exists between recommended and actual practice. Most 
physicians do not use structured developmental screening tools, which could improve 
early detection, in a systematic way.54,56 Physicians instead appear to rely mainly on 
surveillance strategies. 
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 Limited adherence to the schedule of health supervision visits reduces 
opportunities for developmental surveillance and provides an argument for a more 
structured approach to this area of practice. Increasing the use of validated developmental 
screening tools during health supervision visits is one obvious way to improve rates of 
early identification of developmental delays and conditions. Implementation of screening 
guidelines is likely to be complex, however, and will require further research as well as 
public policy initiatives to overcome significant barriers to the use of these tools in practice. 
 
RECOMMENDATIONS 
1. There is a need for ongoing studies to: 
• better understand the reasons for the gap between the known prevalence of 
developmental conditions and their actual identification in early childhood; 
• document the effectiveness of physicians’ developmental monitoring and screening 
efforts over time, as policies to promote developmental screening are implemented; 
• determine the cost and cost-effectiveness of different screening strategies in light of 
the new AAP guidelines for developmental screening; and 
• understand and address any negative consequences of developmental screening. 
 
There have been few systematic, population-based studies, and no recent studies, 
of the timing of the identification of children’s developmental conditions from birth to 
school entry. There is a need for research to elucidate reasons for the gap between the 
known prevalence of developmental conditions and the percentage of children receiving 
treatment services at different ages. 
 
Available data suggest that many, if not most, opportunities to identify young 
children with developmental delays are missed. Studies are needed to determine ways to 
improve use of screening tools in practice. In addition, research is needed to examine the 
fidelity of implementation—to ensure that tools are used in appropriate, validated ways. 
 
Stakeholder input is needed to better define the effectiveness of physicians’ 
developmental monitoring and screening efforts. Effectiveness will likely be defined on 
multiple levels: at a population level, in terms of narrowing the gap between the number 
of children expected to have a condition and the number receiving treatment; and at the 
level of individual children and families, as a decrease in the time lag between initial parent 
or provider concerns and referral to evaluation and treatment services. 
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 Setting benchmarks for the timing of identification of different types of 
developmental delays or conditions would provide useful guides for providers and Early 
Intervention programs. Data collection on the timing of initial identification, referral to 
evaluation and treatment services, and clarification of a child’s diagnosis is needed to 
monitor performance and progress in this area. 
 
In addition, analyses of the costs of screening using different tools following the 
schedule of the revised AAP practice guideline are needed.34 Such analyses should consider 
the cost of dealing with false positive screening results produced by different screening 
methods. Analyses are also needed to examine the effectiveness and cost-effectiveness of 
use of general tools, condition-specific tools, or both. Given the limited adoption of 
developmental screening tools in primary care, it may not be effective to recommend the 
systematic use of condition- or domain-specific tools until there is broader uptake of 
general screening tools. 
 
The limited sensitivity and specificity of screening instruments can lead to 
mislabeling of a child’s developmental status. A false positive result can cause anxiety 
among parents of children whose development is found to be within the normal range on 
further assessment.84 There is a need for research on the potential negative consequences 
to families who receive false positive screening results. In addition, qualitative studies are 
needed to increase providers’ comfort in sharing positive screening results, and determine 
effective and efficient ways for caregivers to provide counseling and information to families. 
 
2. Financial, educational, and other barriers to the use of developmental 
screening tools need to be addressed to promote physicians’ use of these tools. 
Inadequate compensation to providers for administering and interpreting developmental 
screening tools is a major barrier to their use.67 Parent-completed screening questionnaires, 
which reduce the time required of providers, could help, but they are not in common use. 
In addition, all states need to develop policies—already in place in some states—to adequately 
compensate providers for developmental screening.50,85 Enhanced compensation could 
“bundle” developmental screening into the health supervision visit as part of the overall 
care package85 or designate developmental screening as a separate billable component, 
with its own procedural code.34 Research is needed to measure the impact of such 
payment policies on identification of developmental problems and outcomes for affected 
children and their families. 
 
There is an existing procedure code (CPT code 96110) for enhanced reimbursement 
to providers for using a validated tool to perform developmental screening. Yet, insurance 
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 plans may not provide reimbursement for this code. For this reason, physicians may 
hesitate to use the billing code, even if it is reimbursed by Medicaid plans in their state, 
if they think privately insured families will be expected to pay out-of-pocket for this 
service. To encourage developmental screening, both publicly and privately insured 
patients must be billed for this service in a similar manner. Consumers and/or providers 
should advocate for all private insurers to recognize and reimburse this developmental 
screening procedure code. 
 
3. Training residents in pediatrics and family medicine to use developmental 
screening tools as part of the routine care of pediatric patients will ensure that 
the next generation of providers is ready to use developmental screening tools 
in practice. 
The content of training for medical residents, as well as pediatric nurse practitioners, 
significantly affects their future practice. It is therefore imperative that regular use of 
developmental screening tools in the care of pediatric patients be incorporated into 
such training. 
 
4. Resources are needed to develop high-quality screening tools that are available 
in the public domain and compatible with electronic medical record systems. 
Because of concerns about the limited sensitivity and specificity of available screening 
tools, support is needed to develop and refine cost-effective tools that perform well in 
clinical settings. The tools need to take into account the increasingly diverse cultures of 
children and families in the United States. Development and validation of tools with an 
adequate sample of children who are representative of the geographic, socioeconomic, and 
racial/ethnic diversity of the United States will require adequate funding. In addition, 
screening tools should be compatible with electronic medical record systems. 
 
5. Communication models need to be developed to assist physicians in 
discussing the implications of developmental screening test results with families. 
A rich literature exists on “breaking the news” to families of a specific developmental 
diagnosis. Yet, there is no parallel literature on effective ways to discuss the results of 
developmental screening tests, which suggest a potential problem requiring further 
evaluation rather than a specific diagnosis. Communication models could alleviate 
providers’ discomfort and reduce parental anxiety and distress. 
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 6. Adding a 30-month preventive care visit to the visit schedule, as recommended 
by organizations such as Bright Futures, will create more opportunities to 
provide developmental screening and identify developmental delays. 
A 30-month preventive care visit is not currently part of the schedule of routine visits for 
children, but it is recommended in the most recent AAP guidelines on developmental 
surveillance and screening.34 An additional visit between ages 2 and 3 would enable 
providers to screen for developmental problems during a critical time in the child’s 
development, and at an age when children are still eligible for birth-to-3 Early 
Intervention services. 
 
7. Successful models of developmental screening, such as the ABCD program 
in North Carolina, need to be spread to other states. This is already occurring 
through the ABCD Screening Academy, sponsored by NASHP and 
The Commonwealth Fund. 
Approaches such as the office systems model—in which responsibility for different aspects 
of preventive care services is shared among trained office staff, thereby reducing the 
burden on physicians86—could promote developmental screening in primary care. In a 
demonstration project to implement Bright Futures guidelines, the office systems approach 
increased the provision of structured developmental screening from 29 percent to 75 
percent of visits.87
 
In addition, public health approaches have been shown to be effective at increasing 
rates of early detection. For example, the advent of newborn hearing screening has had a 
major impact on the early detection of hearing impairment.88 Connecticut has adopted a 
statewide, coordinated system of identification, triage, and referral for children at risk for 
developmental and behavioral problems.89,90 The system, called Help Me Grow, gives 
providers a single point of access to all developmental programs and services for children 
birth to age 5 through a toll-free referral line. In North Carolina, the success of the 
ABCD program, which promotes use of developmental screening in primary care, has led 
to statewide implementation of the program.85 The state Medicaid program has adopted 
requirements for structured developmental screening using tools as part of a bundled set of 
preventive health services for children.85 Research on the effect of such public policy 
initiatives on detection rates and outcomes, as well as funding to promote successful 
programs in other communities, is needed. 
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 8. Planning and resource allocation at the state and federal levels are needed to 
ensure sufficient resources for evaluation and treatment of the increased 
number of young children who will be identified through systematic 
developmental screening. 
The widely varying rates of participation in Early Intervention services among the states 
mean that where a child lives may greatly affect his or her developmental outcomes. 
Significantly more resources are now devoted to later, mainly remedial special education 
services (through IDEA Part B) than to earlier, often preventive services (through IDEA 
Part C). This means that many opportunities to address children’s delays during a time of 
maximum brain adaptability, the first three years of life, are missed. 
 
Increased use of developmental screening tools by primary care providers will 
inevitably lead to increased identification of developmental delays in young children. 
Planning and resource allocation are needed to ensure that sufficient services will be 
available to meet the needs of children and families. Investment in development and 
continued support of public health programs that improve communication and 
collaboration between primary care providers, Early Intervention and educational 
programs, and providers of assessment and treatment services are needed. Such models will 
address the concerns reported by primary care providers about the lack of, or perceived 
lack of, outlets for children with developmental delays. 
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 Table 1. Prevalence of Developmental Conditions 
Condition Prevalence 
Attention Deficit Hyperactivity Disorder 
— Brown, 200183
 
4% to 12% (median 5.8%) 
Autism/Autism Spectrum Disorders 
— Bertrand, 200184
 
All autism spectrum: 6.7 cases per 1,000 
— Autistic disorder: 4.0 per 1,000 
— PDD-NOS* and Asperger disorder: 
2.7 per 1,000 
Cerebral Palsy 
— Boyle, 19941
— Murphy, 199385
 
2.3 per 1,000 
Cognitive Disability/Mental Retardation 
— Murphy, 19957
 
Overall: 12.0 per 1,000 children 
Mild: 8.4 per 1,000 children 
Severe: 3.6 per 1,000 children 
Hearing Impairment 
— Bhasin, 200686
 
1.2 per 1,000 
Learning Disability 
— Boyle, 19941
 
6.5% 
Speech & Language Delay/Disorder 
— Horwitz, 20034
 
 
 
— Tomblin, 19972
 
Expressive language delays: 
13.5% delay at 18–23 months 
17.5% delay at 30–36 months 
 
Language impairment: 7.4% at kindergarten 
* PDD-NOS is a pervasive developmental disorder, not otherwise specified. 
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 Table 2. Definition of Terms: 
Identification of Developmental Delays 
Term Definition 
Developmental surveillance (monitoring) Use of information from multiple sources 
(parent concerns or questions, asking about 
developmental milestones, informal observation 
of the child, and physical examination) to 
monitor a child’s development over time. 
Developmental screening Systematic use of a validated screening tool to 
identify children likely to have a developmental 
delay, with all children in a practice or 
population, regardless of risk. 
Secondary/selective developmental screening Use of a validated screening tool with a subset of 
children identified as having an increased risk for 
developmental delays. These children might be 
identified through developmental surveillance. 
Developmental assessment/evaluation Formal testing of a child’s developmental skills 
using a standardized assessment tool, and/or 
evaluation by a specialist in the area of child 
development, to determine the specific nature of 
a child’s developmental difficulties and diagnosis. 
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 Table 3. Summary of AAP Recommendations on Developmental 
Surveillance and Screening at Health Supervision Visits (2006)28
A. At each visit: 
— Developmental surveillance 
— If concern during surveillance: do developmental screening 
B. At 9- and 30-month* visits: 
— General developmental screening (all children) 
C. At 18-month visit: 
— General developmental screening (all children) 
— Autism-specific screening (all children) 
D. If positive screen result (A, B, or C): 
— Refer child for developmental and medical evaluation 
— Refer child to Early Intervention services (< 3 years old) 
— Refer child to Early Childhood services (> 3 years old) 
* 30-month visit not currently part of routine health supervision schedule. 
If no 30-month visit planned, screen at 24-month visit. 
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 Table 4. Definition of Terms 
Related to the Properties of Screening Tools 
Term Definition 
Sensitivity The ability of a test to correctly identify those who have a 
condition or disease 
or 
The proportion of children with a condition (developmental delay) 
who are correctly identified as having the condition by the test 
Specificity The ability of a test to correctly identify those who do not have 
a condition or disease 
or 
The proportion of children without a condition (developmental 
delay) who are correctly called negative by the test 
Positive predictive value The proportion of patients with a positive screening result who 
actually have the condition 
 
The predictive value depends on the prevalence of the condition; 
higher prevalence, such as developmental conditions, leads to a 
better predictive value of a screening test result 
Negative predictive value The proportion of patients with a negative screening result who 
do not have the condition 
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